TMED1 and colorectal carcinoma: According to Spearman’s correlation analysis, there were positive correlations observed between the expression of TMED1 and immune checkpoint inhibitors VTCN1 (p = 5.90 × 10−4) and LGALS9 (p = 0.04) in CRC (Figure S1A).